Randomized phase II study of weekly paclitaxel versus paclitaxel and carboplatin as second-line therapy in disseminated melanoma: a multicentre trial of the Dermatologic Co-operative Oncology Group (DeCOG) - Zimpfer, Christine; Figl, Robert; Schadendorf, Dirk (Melanoma research, 2003)
Gesehen am 25.11.2020